
Leukemia & Lymphoma Society
North America, New York, United States, White Plains
Description
Leukemia & Lymphoma Society, a voluntary health organization, funds research, finds cures, and offers treatments for blood cancer patients.
Investor Profile
Leukemia & Lymphoma Society has backed more than 18 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 22% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, Finland, France.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Post Ipo Equity (28%)
- Series B (22%)
- Series C (17%)
- Series Unknown (11%)
- Corporate Round (6%)
- Grant (6%)
- Series D (6%)
- Seed (6%)
Country Focus
- United States (61%)
- Finland (11%)
- France (6%)
- Poland (6%)
- Sweden (6%)
- Germany (6%)
- Switzerland (6%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Pharmaceutical
- Oncology
- Biopharma
- Life Science
- Clinical Trials
- Hospital
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Leukemia & Lymphoma Society frequently co-invest with?
Which angels does Leukemia & Lymphoma Society often collaborate with?
What are some of recent deals done by Leukemia & Lymphoma Society?
Find More Investors Like Leukemia & Lymphoma Society
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides










